Page 28 - Discover Top Biotechnology Partners From Poland - Business Catalogue

Polish Biotechnology Sector Polish Biotechnology Sector

COMPANY NAME: Orphninic Scientific SA COMPANY NAME: Pikralida sp. z o.o.

WEBSITE : https://www.orphinic.com/ WEBSITE : https://www.pikralida.eu/en/
YEAR OF ESTABLISHMENT: 2019 YEAR OF ESTABLISHMENT: 2019
NUMBER OF EMPLOYEES: 12 NUMBER OF EMPLOYEES: 22
CERTIFICATIONS: Our plan is to IPO at Warsaw Stock Exchange by the end of 2023. CERTIFICATIONS: not applicable

PRODUCTS: Orphinic currently has 10 projects in the pipeline - from a preclinical PRODUCTS: Project EpiFix: We are targeting prevention of epilepsy development
phase to market approval stages in three healthcare segments: following traumatic brain injury or stroke. Initiation of phase I clinical
therapeutics, medtech and e-health. Our portfolio represents clinic- trial is scheduled for H2 2023. Project ALS: We are running the scientific
ready assets, with first projects ready to exit in early 2024, and a research project to identify the lead structures and a clinical candidate
preclinical pipeline for long-term value creation in the next few years.
FORM OF COOPERATION: Trade and distribution, Joint Venture, Investment FORM OF COOPERATION: Joint Venture, Investment

Orphinic Scientific S.A. - first Polish biotech portfolio Pikralida is conducting scientific projects aimed at the
platform creating innovative solutions for orphan diseases discovery and development of breakthrough therapeutic
and other indications with significant unmet medical needs solutions offering the response to unmet medical needs of
in the clinical trial phase. Orphinic core scientific team patients. We carry out projects starting from the design of
consist of experts with over 20 years experience in clinical an innovative therapeutic solution up to clinical verification
development processes and their commercialization. The of the idea in the form of proof-of-concept clinical trials.
company’s competencies in clinical stage development are Our portfolio covers the implementation of projects based
further enforced through a collaboration with a large on our original concepts, purchased licences, and based on
clinical CRO operating in the CEE region. This facilitates the revolutionary discoveries of the academic science
access to diverse patient populations and rapid enrollment teams. We are looking for research collaborations and
to clinical trials supporting our projects and significantly partnership with pharmaceutical companies that would
shortens the duration of individual phases. advance clinical development of our lead project.